Ryan Louie Manuel

  • Biography
  • Key Cases

Ryan Louie Manuel specializes in antitrust and class action litigation, and approaches his practice with compassion, perseverance and hard work. He has experience in all stages of litigation, including propounding and responding to discovery requests, coordinating and conducting document discovery, taking depositions, and successfully completing trial-related tasks.

Ryan’s professional qualifications are exemplified by his invaluable work on the Firm’s Capacitors trial. He is heavily involved in providing essential support and preparation for trial, including drafting the exhibit list, assisting in preparing trial witnesses, and daily management of trial logistics.

Prior to joining the Firm, Ryan was a post-bar law clerk for a boutique San Mateo, California litigation firm. He researched legal matters relating to construction defects, contract formation and defenses to the enforceability of a contract. He also assisted counsel by preparing law and motion legal memoranda used by counsel in drafting an opposition to demurrer, settlement demand letters, and motions for summary judgment. He also assisted counsel with case management and strategy, and meeting day-to-day case deadlines.

As a former intern for the California Public Utilities Commission (CPUC), he researched legal and legislative law as part of the CPUC’s Public Advocates Office branch, addressed the CPUC’s responsibilities in implementing Time of Use rate changes and applicability and enforcement of bill protection. He also prepared memoranda on the enforcement of a California judgment upon an out-of-state defendant located in New York and Florida, and researched and prepared internal memos pertaining to the CPUC’s investigatory authority over non-parties and/or non-utility actors who transact business with a public utility affecting rate-payer’s interests.

Ryan is a former judicial extern for the San Francisco County Superior Court probate department, where he drafted bench memos addressing diverse procedural and substantive matters, reviewed and summarized documentary evidence, and observed court proceedings.

While at the University of San Francisco School of Law, Ryan participated in the Intense Advocacy Program and was a legal clinician-student attorney at its Internet and Intellectual Property Clinic. He was the symposium editor of the University of San Francisco Law Review and was president of the Asian Pacific American Law Student Association, Co-Chair President of the Pilipino American Law Society, and Media Chair for the Environmental Law Student and Alumni Society.

Prior to law school, Ryan was a case administrator for a prestigious Bay Area law firm, at which he monitored, supported and managed case docket and staffing for various cases including mass tort class action cases; compiled information in preparation for exchange of FRCP Rule 26 disclosures; trained paralegals and junior attorneys on civil procedure, discovery practice and witness preparation; and co-authored the firm’s paralegal manual.

Mr. Ryan Manuel is a member of the Filipino Bar Association of Northern California, Bay Area Lawyers for Individual Freedom, Asian American Bar Association, Gay Asian Pacific Alliance (GAPA), and National Filipino American Lawyers  Association (NFALA).

  • Capacitors Price-Fixing Antitrust Litigation: The Firm is Sole Lead Counsel in a class-action lawsuit alleging that global capacitor manufacturers conspired to fix prices, forcing direct purchasers to pay more. The class is certified and trial is proceeding in 2021. Initial settlements in the case total $343.5 million;
  • Defense Contractor “No-Poach” Litigation: The Firm represents defense intelligence workers who allege that Booz Allen Hamilton, Inc., CACI International, Inc., and Mission Essential LLC entered into unlawful agreements not to hire one another’s workers, which had the purpose and effect of suppressing workers’ compensation; and
  • Generic Drug Price-Fixing Antitrust Litigation: The Firm is on the Plaintiffs’ Steering Committee representing U.S. consumers and insurers in a multi-district antitrust litigation accusing several generic drug manufacturers with conspiring to fix and raise prices for dozens of generic medications. In the past few years, prices for these drugs have skyrocketed by more than 1,000 percent. Consumers blame the companies for engineering these price hikes, eliminating the benefits of competition, and forcing them to pay exorbitant prices. The Firm is also currently investigating many other generic drugs for potential class action claims.